Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Santen

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Santen's Japan sales performance.

FDA advisors say no to empagliflozin in type 1 diabetes

FDA advisors say no to empagliflozin in type 1 diabetes Europe as well as Japan.

Pharmaceutical innovation in the APAC region

Pharmaceutical innovation in the APAC region We examined these factors for Mainland China, Japan and South Korea, concluding, very broadly:. ... Cancer will remain a growth market, although Japan is currently experiencing price containment pressures that other countries will also ultimately face.

Sandoz expands into Japan with €400m Aspen deal

Sandoz expands into Japan with €400m Aspen deal The acquisition will include shares in Aspen Japan K.K. and all associated assets held by AGI. ... Japan’s generic medicines market is the third largest globally, a fact which will aid Sandoz’ continuing growth – in Novartis’ recent third

Daiichi files lawsuit with Seattle over ADCs, including AZ-partnered DS-8201

Daiichi files lawsuit with Seattle over ADCs, including AZ-partnered DS-8201 Dispute covers multiple drugs in Daiichi's antibody-drug conjugates pipeline. A partnership between Seattle Genetics and Japan’s Daiichi Sankyo on antibody-drug conjugates, which ended in 2015, has sparked

GSK boosts outlook thanks to strong respiratory and vaccine sales

GSK boosts outlook thanks to strong respiratory and vaccine sales This was driven by a strong trajectory in the US, and GSK is also looking “forward to our phased launches in China and Japan next year”, GSK’s president of global

[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...

Infographics